Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine in Chronic Limb-Threatening Ischemia
NCT07536373Phase 3Recruiting
- Sponsor
- Shin Kong Wu Ho-Su Memorial Hospital
- Start
- Jun 2026
- Primary completion
- Apr 2029
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of colchicine in chronic limb-threatening ischemia (CLTI), sponsored by Shin Kong Wu Ho-Su Memorial Hospital. Started Jun 2026; status: recruiting.
02
Drugs
colchicine
03
Conditions
chronic limb-threatening ischemia (CLTI)
Beyond the preview
Go deeper on NCT07536373.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07536373.